Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Evaluating FOLFIRI plus cetuximab or bevacizumab in advanced colorectal cancer

Evaluating FOLFIRI plus cetuximab or bevacizumab in advanced colorectal cancer

Posted by on Nov 30, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of FOLFIRI (5-fluorouracil, folinic acid, and irinotecan) with either cetuximab (Erbitux) or bevacizumab (Avastin) in the treatment of advanced colorectal cancer (CRC). Researchers suggested that FOLFIRI with cetuximab resulted in improved response and longer survival for these patients. Some...

Read More

Hybrid assistive limb robot training improves daily living activities in patients with stroke

Hybrid assistive limb robot training improves daily living activities in patients with stroke

Posted by on Nov 29, 2020 in Stroke | 0 comments

In a nutshell This study investigated if lower limb robot training (LLRT) using the Hybrid Assistive Limb (HAL) device improves daily living in patients with stroke. Researchers suggested that HAL improves daily activities and walking ability in these patients. Some background A stroke consists of a blockage of the blood flow to the brain. This...

Read More

Comparison of benidipine and amlodipine in the management of patients with high blood pressure and chronic kidney disease

Comparison of benidipine and amlodipine in the management of patients with high blood pressure and chronic kidney disease

Posted by on Nov 29, 2020 in Hypertension | 0 comments

In a nutshell This study compared two treatments for lowering blood pressure (BP) in patients with high BP and chronic kidney disease (CKD). They found that there was no difference in the BP-lowering effect between the two drugs. Some background The kidneys are responsible for filtering water out of the blood and producing urine. The...

Read More

Do SGLT2 inhibitors with or without metformin improve heart and kidney health?

Do SGLT2 inhibitors with or without metformin improve heart and kidney health?

Posted by on Nov 29, 2020 in Diabetes mellitus | 0 comments

In a nutshell This review looked at how SGTL2 inhibitors with or without metformin (Glucophage) affect heart and kidney health for patients with type 2 diabetes (T2D). It found that these medications improve cardiovascular and kidney outcomes, whether or not patients are also taking metformin. Some background SGLT2 inhibitors are a group of T2D...

Read More

Plaque incision or excision and grafting of collagen TachoSil improves the outcomes of patients with Peyronie’s disease

Plaque incision or excision and grafting of collagen TachoSil improves the outcomes of patients with Peyronie’s disease

Posted by on Nov 29, 2020 in Erectile dysfunction | 0 comments

In a nutshell This study investigated the effectiveness and safety of plaque incision/excision and or grafting (PIG/PEG) with collagen TachoSil to treat erectile dysfunction in patients with Peyronie's disease (PD). Researchers suggested that PIG/PEG is a good and safe procedure to treat these patients. Some background PD consists of...

Read More

Irinotecan combined with capecitabine-based chemoradiotherapy before surgery improves the outcomes of patients with rectal cancer

Irinotecan combined with capecitabine-based chemoradiotherapy before surgery improves the outcomes of patients with rectal cancer

Posted by on Nov 29, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of treatment with irinotecan (Camptosar) combined with capecitabine (Xeloda) chemotherapy (ICC) before rectal cancer surgery. Researchers suggested that this combined therapy significantly improved the treatment outcomes in these patients. Some background Rectal cancer is a common...

Read More

Could venetoclax combined with bortezomib and dexamethasone help to treat patients with relapsed/refractory multiple myeloma?

Could venetoclax combined with bortezomib and dexamethasone help to treat patients with relapsed/refractory multiple myeloma?

Posted by on Nov 28, 2020 in Multiple Myeloma | 0 comments

In a nutshell This study investigated whether giving patients with relapsed/resistant multiple myeloma (MM) venetoclax (Venclexta), in combination with bortezomib (Velcade) and dexamethasone (Ozurdex), will improve patient survival. This study showed that these patients would benefit from this treatment combination. Some background...

Read More

Does giving radiotherapy to metastatic sites and the prostate tumor improve the outcomes of patients with prostate cancer and few metastases?

Does giving radiotherapy to metastatic sites and the prostate tumor improve the outcomes of patients with prostate cancer and few metastases?

Posted by on Nov 25, 2020 in Prostate cancer | 0 comments

In a nutshell This study aims to evaluate if giving radiotherapy to both the areas the tumor has spread (metastases), along with the prostate tumor, will improve the survival of patients with prostate cancer (PC) and few metastases (oligometastatic disease). This study suggested that this treatment could benefit patients with PC and few...

Read More